Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Total Liabilities (2024 - 2026)

Updated

Lb Pharmaceuticals' Total Liabilities was $29.35 million in Q2 2026, up 98.4% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Total Liabilities at Lb Pharmaceuticals came in at $11.62 million, down 90.9% from FY2024.

  • In earlier years, Total Liabilities was $128.09 million in FY2024.
  • The Q2 2026 figure marks the highest quarterly Total Liabilities since Q4 2024.
  • Per Business Quant data, LBRX's Total Liabilities in the three quarters before Q2 2026 was $14.79 million (Q1 2026), $11.62 million (Q4 2025) and $10.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 115.90 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 152.26 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 38.37 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.70 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - 35.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 35.73 Mn
Jun 30, 2026 29.35 Mn
Mar 31, 2026 14.79 Mn
Dec 31, 2025 11.62 Mn
Sep 30, 2025 10.53 Mn
Dec 31, 2024 128.09 Mn
API Access

Lb Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=LBRX&period=max&api_key=YOUR_API_KEY